Back to School: How biopharma can reboot drug development. Access exclusive analysis here

New Banexi fund to incorporate biotech

New Banexi fund to incorporate biotech

Banexi Corp., the international merchant banking arm of Banque Nationale de Paris, and Nazem & Co., a Menlo Park, Calif., venture capital firm,

Read the full 293 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE